Dexcom (DXCM) Work In Process (2010 - 2026)

Dexcom (DXCM) has 13 years of Work In Process data on file, last reported at $136.0 million in Q1 2026.

• Work In Process for Q1 2026 came in at $136.0 million, up 111.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $136.0 million (up 111.51% YoY), and the FY2025 annual result was $105.0 million, up 273.67% from the prior year.
• Work In Process advanced to $136.0 million in Q1 2026 per DXCM's latest filing, from $105.0 million in the prior quarter.
• Over five years, Work In Process peaked at $136.0 million in Q1 2026 and troughed at $15.8 million in Q1 2022.
• A 5-year average of $51.6 million and a median of $36.4 million in 2023 frame the typical range for Work In Process.
• The sharpest annual moves came in 2023 and 2025: Work In Process slipped 12.97% in 2023, then jumped 273.67% in 2025.
• A 5-year view of Work In Process shows it stood at $17.2 million in 2022, then surged by 74.42% to $30.0 million in 2023, then dropped by 6.33% to $28.1 million in 2024, then jumped by 273.67% to $105.0 million in 2025, then climbed by 29.52% to $136.0 million in 2026.
• Business Quant data shows DXCM's Work In Process at $136.0 million in Q1 2026, $105.0 million in Q4 2025, and $78.6 million in Q3 2025.